Author

Sujan Piya

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-8976-540XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:deep learning· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Aaron A. Bickert· 1 shared Adrian PerdyaniD· 1 shared Alens ValentiniD· 1 shared Amari M. SockwelliD· 1 shared Ana S. Maldonado· 1 shared André ForjaziD· 1 shared Anirban MaitraiD· 1 shared Ashley L KiemeniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron A. Bickert

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer

André Forjaz, Hengameh Mojdeganlou, Alens Valentin, Meredith Wetzel, Dmitrijs Lvovs, Atul M. Deshpande, Sarah M. Shin, Sujan Piya, Kimal Rajapakshe, Paola Guerrero, Brian A. Pedro, Dimitrios N. Sidiropoulos, Pei-Hsun Wu, Vincent Bernard Pagan, Demystifying Pancreatic Cancer Therapies TeamLab, , Laura DeLong Wood

The paper develops a 3D multi-omic pipeline using deep learning to analyze chemotherapy response in pancreatic cancer, identifying molecular signatures of resistance and fibroblast-cancer interactions.

bioRxiv · Mar 5, 2026 · PreprintCancer Biology

Distinct small molecule inhibitors of Kras specifically prime CTLA4 blockade therapy to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer

Krishnan K. Mahadevan, Ana S. Maldonado, Bingrui Li, Aaron A. Bickert, Adrian Perdyan, Shreyasee V. Kumbhar, Sujan Piya, Amari M. Sockwell, Sami J. Morse, Kent A. Arian, Hikaru Sugimoto, Shabnam Shalapour, David S. Hong, Timothy Paul Heffernan, Anirban Maitra, Raghu Kalluri

This study identifies small molecule Kras inhibitors that synergize with anti-CTLA4 therapy to reprogram Tregs and enhance immunotherapy efficacy in PDAC.

bioRxiv · Feb 28, 2025 · PreprintCancer Biology